Eighty-three percent of clinical trial patients remained with Virta at one year.¹ 60% reversed type 2 diabetes. This is the new normal in diabetes care.
Virta's approach reduces the need for prescription medications. At one year, clinical trial patients eliminated 63% of diabetes-specific medications. 94% of patients eliminated or reduce insulin usage.¹
Virta patients see sustained improvement in HbA1c, on average experiencing a 1.3 point drop at one year. Meanwhile, patients receiving Usual Care saw no improvement in HbA1c.¹
Improved metabolic health is our primary focus, but our patients lose weight, too—one of the many "side benefits" of the Virta Treatment. At one year, clinical trial patients lost 30 lbs. on average, or 12% of total body weight.¹
Our fast results and high-touch, individualized approach combine to deliver behavioral change that patients stick with for the long-term
Our patients continue to eliminate medications like insulin beyond year 1, with 55% of completing patients achieving diabetes reversal at two years.²
Our ongoing clinical trial, now in its fifth year, is demonstrating what is possible when patients have a treatment and care team that work for them.See our research